Your doctor has prescribed an IVF protocol. Perhaps they said "we'll do a short protocol" or "GnRH antagonist protocol" or "long down-regulation." What does any of this mean?

An IVF protocol is the specific regimen of medications and timing used to stimulate your ovaries, prevent premature ovulation, trigger egg maturation, and retrieve eggs. Different protocols use different medications, in different sequences, for different patient profiles.

Getting the protocol right matters. A PCOS patient using the wrong protocol could end up hospitalized with OHSS. A poor responder on the wrong protocol may get fewer eggs than they would otherwise. Your clinic should be selecting your protocol based on your specific AMH, AFC, age, and diagnosis.

This article explains the four main protocol types used in India, with the medications involved, the rationale, and who each is best suited for.

Key Takeaways

  • The GnRH antagonist protocol is currently the most common in India — shorter, simpler, and lower OHSS risk.
  • The long agonist protocol (long down-regulation) is the traditional standard — still used for normal and some poor responders.
  • Mini-IVF uses lower medication doses; appropriate for poor responders, older patients, or those avoiding high medication loads.
  • Natural cycle IVF uses no stimulation; for specific patient groups only.
  • Your protocol should be chosen based on your ovarian reserve, age, and risk profile — not as a one-size-fits-all standard.

The Core Problem All Protocols Solve

To retrieve multiple eggs in IVF, the ovaries must be stimulated to grow many follicles simultaneously (superovulation). This is done with gonadotropins — injectable FSH (follicle-stimulating hormone) with or without LH.

But there's a problem: if the body's own pituitary gland senses rising estrogen from the growing follicles, it will release an LH surge, triggering premature ovulation. The eggs would be released before retrieval.

All protocols solve this problem in one of two ways:

  1. 1Downregulate (suppress) the pituitary using a GnRH agonist (long protocol)
  2. 2Blockade the pituitary using a GnRH antagonist (short/antagonist protocol)

The difference in how they prevent premature LH surge determines most of the clinical differences between protocols.

Protocol 1: GnRH Antagonist Protocol (Short Protocol)

Also called: Short protocol, antagonist protocol, flexible antagonist protocol

How it works:

Day: Day 2-3 of period · Action: Start gonadotropin injections (FSH ± LH)

Day: Day 5-6 of stimulation · Action: Add GnRH antagonist (Cetrorelix/Ganirelix/Orgalutran) daily

Day: Days 6-12 · Action: Continue both gonadotropin + antagonist; monitoring scans every 1-3 days

Day: When follicles ≥ 17-18 mm · Action: Trigger shot

Day: 34-36 hours later · Action: Egg retrieval

Medications used in India:

Gonadotropins (stimulation):

  • Gonal-F (follitropin alfa) — 75 IU, 150 IU, 300 IU, 450 IU pens — Rs 1,200–4,500 per pen
  • Puregon (follitropin beta) — pens — Rs 900–2,800 per pen
  • Rekovelle (follitropin delta) — prefilled pen — Rs 1,500–3,500 per pen
  • Fostimon (urofollitropin — urinary FSH) — Rs 600–1,200 per vial
  • HMG-based (combined FSH+LH): Menogon, Menopur, Merional — Rs 700–2,500 per vial

GnRH Antagonist:

  • Cetrotide (cetrorelix) 0.25 mg SC daily — Rs 2,000–3,500 per injection
  • Orgalutran/Fyremadel (ganirelix) 0.25 mg SC daily — Rs 2,000–3,000 per injection

Trigger options:

  • hCG (Ovitrelle, Pregnyl) — standard
  • GnRH agonist (Lupride 0.2 mg SC) — if high OHSS risk, allows freeze-all

Total stimulation duration: ~10-12 days Total medication cost: Rs 40,000–80,000 depending on dose

Who it's best for:

  • PCOS patients (can use agonist trigger to prevent OHSS)
  • Normal responders (most common first-line protocol)
  • Most patients in 2026 — this is now the dominant protocol globally

Advantages:

  • Shorter treatment course
  • Less medication total
  • Allows flexibility in timing
  • GnRH agonist trigger option dramatically reduces OHSS risk
  • No need for "down-regulation" period

Disadvantages:

  • Slightly more complex medication schedule (adding antagonist mid-cycle)
  • Some evidence suggests marginally lower yield in some patient profiles vs long protocol (but outcomes data is equivalent)

Protocol 2: Long GnRH Agonist Protocol (Long Down-Regulation)

Also called: Long protocol, long agonist protocol, down-regulation protocol, the "long lupron" (after the brand Lupron/Leuprolide)

This was the standard IVF protocol for 20+ years and is still widely used in India.

How it works:

The GnRH agonist paradoxically initially stimulates the pituitary (flare), then — with continued use — causes profound suppression of FSH and LH production. This "downregulation" takes about 10-14 days. Once the pituitary is suppressed and checked (Day 2/3 of next period — low estrogen, quiet ovaries on scan), gonadotropin stimulation begins.

Timing: Luteal phase (Day 21 of previous cycle) · Action: Start GnRH agonist (Lupride/Decapeptyl)

Timing: ~10-14 days later (next period Day 2-3) · Action: Check downregulation: blood + ultrasound

Timing: If downregulated: continue agonist + start gonadotropins

Timing: Days 10-15 of stimulation · Action: When follicles ready: trigger shot

Timing: 34-36 hours later · Action: Egg retrieval

Medications:

  • Lupride (leuprolide acetate) 0.5–1 mg SC daily for downregulation; dose typically reduced to 0.1–0.5 mg during stimulation phase — Rs 400–800 per vial
  • Decapeptyl (triptorelin) — monthly depot (3.75 mg) or daily SC — Rs 2,000–4,000
  • Then gonadotropins (same as above) during stimulation phase

Total treatment duration: ~28-35 days (from start of agonist to retrieval)

Who it's best for:

  • Poor responders (older women, low AMH) — some evidence suggests better egg quality with suppressed background LH
  • Patients with endometriosis — pre-treatment with agonist may suppress endometriotic activity
  • Patients with high LH (can suppress before stimulating)
  • Patients where precise scheduling is needed

Advantages:

  • Well-established — most clinical data exists for this protocol
  • Good pituitary suppression — very low premature LH surge risk
  • Possibly better egg cohort consistency

Disadvantages:

  • Longer treatment — typically 4-5 weeks from start to retrieval
  • More medication, higher cost
  • Higher OHSS risk (cannot use GnRH agonist trigger because pituitary is already suppressed with agonist — trigger must be hCG)
  • Worse OHSS control — this is its key disadvantage compared to antagonist protocol
  • More monitoring visits

Protocol 3: Short GnRH Agonist Protocol (Flare Protocol / Microflare)

Less commonly used. Uses the initial stimulatory "flare" effect of GnRH agonist (before suppression sets in) to boost endogenous FSH at the start of stimulation.

Used for: Poor responders — patients with very low AMH, older age, low AFC. The flare of FSH may help recruit more follicles in patients who respond poorly to standard protocols.

Disadvantage: Unpredictable flare — elevated LH from the flare may affect egg quality.

This protocol is less commonly prescribed in India since antagonist protocols with modified stimulation have largely replaced it for poor responders.

Protocol 4: Mini-IVF (Minimal Stimulation IVF)

Also called: Mini IVF, minimal stimulation, MS-IVF

Mini-IVF uses significantly lower doses of medications — or oral agents (clomiphene or letrozole) — instead of high-dose injectable gonadotropins.

Goal: Fewer eggs (3-5 instead of 10-15), but with potentially better quality, lower cost, and lower medication burden.

Common mini-IVF approaches:

  1. 1Clomiphene-based: Clomiphene citrate 50-100 mg orally for Days 3-7 + low-dose gonadotropins ± antagonist
  2. 2Letrozole-based: Letrozole 5 mg for Days 3-7 + low-dose gonadotropins
  3. 3Low-dose gonadotropin only: 75-150 IU FSH daily (vs 225-450 IU in standard protocols)

Medications cost: Rs 10,000–30,000 vs Rs 40,000–80,000 for conventional

Who might benefit:

  • Poor responders (already getting few eggs on standard doses — mini-IVF may give similar eggs at lower cost and with fewer side effects)
  • Women with diminished ovarian reserve who prefer a gentler approach
  • Patients who have had severe OHSS and want minimal stimulation
  • Older patients (> 40) for whom multiple cycles of mini-IVF may be planned as a strategy
  • Patients with medical conditions precluding high-dose medications

Disadvantages:

  • Fewer embryos per cycle
  • May require multiple cycles to achieve desired number of embryos
  • Not appropriate for normal or high responders (suboptimal use of ovarian potential)

Evidence: Mini-IVF live birth rates per cycle are lower than conventional IVF. Per-baby cost may or may not be lower, depending on how many cycles are needed. The patients who benefit most are those who would have gotten only a few eggs anyway.

Protocol 5: Natural Cycle IVF

Completely unmedicated. Monitors the patient's natural cycle, retrieves the one naturally developing dominant follicle, fertilizes the egg, and transfers the embryo.

Who uses it:

  • Women with very poor ovarian reserve (low AMH, very few follicles) — stimulation would give the same result as natural cycle
  • Women who cannot tolerate gonadotropins for medical reasons
  • As part of a "natural cycle FET" where monitoring is used but no stimulation

Limitations:

  • One egg per cycle
  • Cycle cancellation risk (natural LH surge may occur before retrieval)
  • Very low chance of success per cycle (though the egg may be high quality)
  • Requires multiple attempts
  • Not suitable for most patients

Protocol Comparison Table

Feature: Duration · Antagonist: 10-12 days stimulation · Long Agonist: 28-35 days total · Mini-IVF: 10-14 days · Natural: ~14 days monitoring

Feature: Injections/day at peak · Antagonist: 2-3 · Long Agonist: 2-3 · Mini-IVF: 1-2 · Natural: None or minimal

Feature: Medication cost · Antagonist: Rs 40,000–80,000 · Long Agonist: Rs 50,000–90,000 · Mini-IVF: Rs 10,000–30,000 · Natural: Minimal

Feature: Expected eggs · Antagonist: 8-15 · Long Agonist: 8-15 · Mini-IVF: 2-5 · Natural: 1

Feature: OHSS risk · Antagonist: Lower (agonist trigger possible) · Long Agonist: Higher · Mini-IVF: Low · Natural: Very low

Feature: Good for PCOS? · Antagonist: Yes (first choice) · Long Agonist: No (high OHSS risk) · Mini-IVF: Acceptable · Natural: No

Feature: Good for poor responders? · Antagonist: Yes · Long Agonist: Yes (possibly) · Mini-IVF: Yes · Natural: Yes

Feature: Good for normal responders? · Antagonist: Yes (first choice) · Long Agonist: Yes · Mini-IVF: Not optimal · Natural: No

Feature: CanUse agonist trigger? · Antagonist: Yes · Long Agonist: No · Mini-IVF: Yes (if antagonist-based) · Natural: N/A

How Your Protocol Is Chosen

Your fertility specialist should consider:

Factor: AMH · Influences Protocol Choice: Low AMH → poor responder protocols (mini, antagonist with higher dose)

Factor: AFC · Influences Protocol Choice: High AFC + PCOS → antagonist + agonist trigger

Factor: Age · Influences Protocol Choice: > 38 → antagonist with gentle stimulation OR mini-IVF

Factor: Previous response · Influences Protocol Choice: High responder history → antagonist + agonist trigger + freeze-all

Factor: Previous cycle failures · Influences Protocol Choice: May change protocol based on what happened

Factor: Endometriosis · Influences Protocol Choice: Long agonist sometimes preferred

Factor: Patient preference · Influences Protocol Choice: Time, medications, cost

Questions to Ask Your Doctor

Questions to Ask Your Doctor 1. Which protocol are you recommending for me, and why specifically for my AMH/AFC? 2. If I've done a previous protocol that didn't work well, should we change protocols this time? 3. What is my OHSS risk on this protocol, and how will we manage it? 4. Can I use a GnRH agonist trigger to reduce OHSS risk? 5. Is mini-IVF an option given my ovarian reserve, and how would outcomes compare? 6. What are the total medication costs for this protocol? 7. How many clinic visits will I need during stimulation monitoring?

Medical Disclaimer This article is for informational and educational purposes only. IVF protocol selection is a complex medical decision that must be made by your fertility specialist based on your individual hormonal profile, history, and clinical circumstances. Medication names and doses mentioned are for educational context only — never self-prescribe. This is not medical advice.

Join GarbhSaathi — India's independent fertility journey companion.